Primary Graft Dysfunction
Primary Graft Dysfunction
Explore linked clinical trials. Standard reference: MESH:M05129214 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Primary Graft Dysfunction, cardiovascular disorder, ischemia reperfusion injury, vascular disorder | Recruiting | Not stated | 2026-07-22 | NCT00552357 | |
| Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Primary Graft Dysfunction, cardiovascular disorder, ischemia reperfusion injury, vascular disorder | Active, not recruiting | Not stated | 2026-07-22 | NCT00457847 | |
| Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Primary Graft Dysfunction, cardiovascular disorder, ischemia reperfusion injury, vascular disorder | Recruiting | Not applicable | 2026-07-13 | NCT07230886 | |
| This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction | Lung Injury, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Primary Graft Dysfunction, acute lung injury, cardiovascular disorder, ischemia reperfusion injury, lung disorder, respiratory system disorder, vascular disorder | Recruiting | Phase 2 | 2026-01-20 | NCT06853223 |